[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TANAKA et al., 2007 - Google Patents

Two cases of bisphosphonate-associated osteonecrosis of the mandible

TANAKA et al., 2007

View PDF
Document ID
3431996388907056132
Author
TANAKA N
KISHIMOTO H
TAKAOKA K
HASHITANI S
SAKURAI K
URADE M
Publication year
Publication venue
Japanese Journal of Oral and Maxillofacial Surgery

External Links

Snippet

In recent years, bisphosphonates inhibiting bone resorption have been used to treat multiple myeloma, bone metastases from mammary and prostate carcinomas, and osteoporosis and have been proven to be useful. However, mainly in Europe and the USA, osteonecrosis of …
Continue reading at www.jstage.jst.go.jp (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P-C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P-C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
EP1339411B1 (en) Use of zoledronic acid for pain treatment
Russell Bisphosphonates: mode of action and pharmacology
Barbosa et al. Bisphosphonates, old friends of bones and new trends in clinics
JP4722375B2 (en) Administration of biphosphonate
JP2009522369A5 (en)
RU2011115356A (en) COMPOSITION CONTAINING INHIBITING CRYSTALLIZATION OF SUBSTANCE
ES2253136T1 (en) PROCEDURE TO INHIBIT THE OSEA RESORTION.
Shima et al. Inflammatory effects of nitrogen-containing bisphosphonates (N-BPs): modulation by non-N-BPs
JP2006500401A5 (en)
TANAKA et al. Two cases of bisphosphonate-associated osteonecrosis of the mandible
F Barghash et al. Pathophysiology of metastatic bone disease and the role of the second generation of bisphosphonates: from basic science to medicine
Shipman, Michael J. Rogers, Karin Vanderkerken, Ben Van Camp, R. Graham G. Russell, Peter I. Croucher Bisphosphonates-mechanisms of action in multiple myeloma
Lazar et al. Bisphosphonates in bone diseases treatment
Berardi et al. Potential applications of biphosphonates in dental surgical implants
Nayak Application of Bisphosphonates in Dentistry: A Review of Literature.
Goodchild et al. What do you really need to know about bisphosphonates?
Bando et al. Release of Nitrogen-Containing Bisphosphonates (NBPs) from Hydroxyapatite by Non-NBPs and by Pyrophosphate
Schmidt et al. Alendronate inhibition of protein tyrosine phosphatase activity
US8623845B1 (en) Pharmaceutical composition for preventing or treating Diabetes mellitus comprising bisphophonates
Park et al. Mechanism, prevention, risk assessment and treatment in bisphosphonates induced osteonecrosis of the jaw
Berenson Advances in the biology and treatment of myeloma bone disease
Jayalakshmi et al. Bisphosphonates in Oral Diseases: Updates of its implications in Dental Management.
Pavkovic et al. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphanates
Henk et al. Clinical findings and main considerations of the use of bisphosphonate in dental implants: a concise systematic review
A Lawson et al. Bisphosphonate therapy in the treatment of multiple myeloma